|
Volumn 1, Issue 5, 2005, Pages 359-360
|
Epstein-Barr virus triggered rejection after kidney allograft transplantation
|
Author keywords
Epstein Barr virus; Kidney transplantation; Rejection
|
Indexed keywords
AZATHIOPRINE;
BASILIXIMAB;
CREATININE;
CYCLOSPORIN A;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
UREA;
VIRUS DNA;
ACUTE GRAFT REJECTION;
ARTICLE;
CADAVER KIDNEY;
CASE REPORT;
CREATININE BLOOD LEVEL;
DISEASE ASSOCIATION;
DNA DETERMINATION;
DRUG MEGADOSE;
DRUG SUBSTITUTION;
EPSTEIN BARR VIRUS;
EXPLANT;
GRAFT INFECTION;
GRAFT SURVIVAL;
HIGH RISK PATIENT;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION RISK;
KIDNEY BIOPSY;
KIDNEY FAILURE;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MALE;
PERITONEAL DIALYSIS;
PLASMAPHERESIS;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
RETREATMENT;
SEROLOGY;
UREA BLOOD LEVEL;
VIRUS INFECTION;
VIRUS REACTIVATION;
|
EID: 32544435632
PISSN: 14775131
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jpurol.2005.01.014 Document Type: Article |
Times cited : (2)
|
References (4)
|